Albumin microspheres as a drug delivery system for dexamethasone: pharmaceutical and pharmacokinetic aspects
- 1 November 1993
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 45 (11) , 987-989
- https://doi.org/10.1111/j.2042-7158.1993.tb05642.x
Abstract
Four types of albumin microspheres containing dexamethasone prepared by varying cross-linking time—30, 60, 120 and 180 min—were tested to examine the influence of heat cross-linking degree on the in-vitro drug release. Release rate of dexamethasone associated with the microspheres was slower for samples with a longer time of high temperature denaturation. Encapsulation in neat-stabilized albumin microspheres for 60 min at 100°C significantly retards the in-vivo release of dexamethasone and hence retards absorption from the injection site.Keywords
This publication has 6 references indexed in Scilit:
- Quantitation of the release of doxorubicin from colloidal dosage forms using dynamic dialysisJournal of Pharmaceutical Sciences, 1987
- Albumin microspheres. I. Release characteristics of adriamycinInternational Journal of Pharmaceutics, 1986
- Development of specific organ targeting drug delivery system II: Physico-pharmaceutical study on the cross-linked albumin microspheres containing cytarabineArchives of Pharmacal Research, 1986
- Simultaneous Determination of Corticosterone, Hydrocortisone, and Dexamethasone in Dog Plasma Using High Performance Liquid ChromatographyJournal of Pharmaceutical Sciences, 1982
- Serum Albumin Beads: An Injectable, Biodegradable System for the Sustained Release of DrugsScience, 1981
- Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJournal of Pharmaceutical Sciences, 1963